Novartis Pharmaceuticals Coporation | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Novartis Pharmaceuticals Coporation

Sort by

Viewing results 1‒25 of 1528

GSK PLC
GSK on hunt for drug deals in China
...Miels said that the pharmaceutical company has since “rebuilt” its business in China....
December 17, 2023
Drugs research
Novartis scraps drug trial in blow to UK life sciences ambitions
...A Swiss pharmaceutical group has scrapped plans to conduct a major drug trial in the UK, damaging government efforts to showcase the country as an attractive destination for investment in life sciences after...
March 22, 2023
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
UK politics
‘Cultural sniffiness’ over profit is hurting NHS drug trials, Labour warns
...This article has been amended to clarify details of the proposed drug trial by the NHS and Novartis...
May 12, 2023
News updates from January 31: Federal Reserve holds interest rates, EU commits €21bn in Ukraine military aid
Novartis boosts sales by 10% as heart and arthritis medicines help beat guidance
...Novartis notched a 10 per cent increase in sales in 2023 as strong performance for its heart and arthritis medicines helped Europe’s second-largest pharmaceuticals company beat its guidance for the year....
January 31, 2024
AstraZeneca PLC
AstraZeneca strikes $2.4bn deal for radiotherapy biotech Fusion
...AstraZeneca has acquired oncology biotech Fusion Pharmaceuticals for $2.4bn to build its expertise and challenge Swiss company Novartis in the developing field of a more targeted form of radiotherapy....
March 19, 2024
Drug prices
Pharmaceutical industry close to deal with UK on drug pricing, says Novartis
...The pharmaceutical industry is close to agreeing a deal with the UK government over drug pricing, according to the chief financial officer of Swiss drugmaker Novartis....
October 24, 2023
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
LexNovartis AG
Novartis: CEO needs to convince over long-term prospects Premium content
...Where doubts creep in is how Novartis will replace lost sales from 2027....
November 28, 2023
News updates from October 24: Alphabet’s cloud unit misses on sales, UK unemployment rises to 4.2%
Pharma industry close to deal with UK on drug pricing, Novartis says
...The pharmaceutical industry is close to agreeing a deal with the UK government over drug pricing, according to the chief financial officer of Swiss drugmaker Novartis....
October 24, 2023
News updates from January 3: US job openings fall to 32-month low, Blasts kill about 100 in Iran
Risers and fallers in Europe
...Big share price moves in Europe this morning include Swiss pharmaceutical group Novartis, London-listed betting group Entain and French maker of rail infrastructure Alstom....
January 3, 2024
Novartis AG
Novartis plans to spin off Sandoz in October
...focused Novartis”....
August 18, 2023
Deepmind Technologies Ltd
DeepMind spin-off aims to halve drug discovery times following Big Pharma deals
...Hassabis stated the goal days after announcing Isomorphic Lab’s first two pharmaceutical partnerships with Eli Lilly and Novartis, which came to a combined value of up to $3bn, in deals set to transform...
January 10, 2024
News updates from January 9: False SEC post swings bitcoin price, Eurozone unemployment falls to record low
GSK agrees to buy respiratory medicine specialist Aiolos Bio for $1.4bn
...The deal comes as pharmaceutical companies gather in San Francisco for an annual industry conference, with GSK rivals Johnson & Johnson, Novartis and Merck announcing acquisitions on Monday....
January 9, 2024
LexPharmaceuticals sector
Big Pharma still needs trial success to overcome looming patent panic Premium content
...Pharmaceutical companies must replenish their drugs pipeline before exclusivity rights on top-selling products expire....
February 6, 2024
Novartis AG
Novartis plans $15bn buyback after failing to find deals
...Shares in Novartis were up just over 3 per cent in early trading on Tuesday, but have languished this year....
July 18, 2023
Live news updates from July 18: BBC hires Deloitte to review procedures, Morgan Stanley profits fall
Novartis launches $15bn share buyback as strong sales boost outlook
...Swiss pharmaceutical giant Novartis has launched a $15bn share buyback programme after raising its outlook for the year on the back of strong sales....
July 18, 2023
FT Live
Due Diligence Live
Where leaders in investment and finance meet
Tuesday, 8 OctoberLondon, UK
GSK PLC
GSK agrees to buy respiratory medicine specialist Aiolos Bio for $1.4bn
..., and Merck and Novartis signing smaller deals on Monday....
January 9, 2024
The Big Read
The world’s broken market for medicines
...was so appalling, no one else bothered to invest capital to enter that space because it wasn’t an attractive market,” says Richard Saynor, chief executive of Sandoz, a generics manufacturer spun-out from Novartis...
March 28, 2024
Drug prices
Novartis boss warns US drug pricing reform poses risk to public health
...The US is the largest pharmaceutical market, mainly because it pays the most in the world for drugs....
July 25, 2023
Eli Lilly & Co
Eli Lilly to buy cancer specialist Point for $1.4bn
...Novartis chief executive Vas Narasimhan said in 2021 that he believed the radioligand market could be worth up to $10bn....
October 3, 2023
Special ReportEurope’s Leading Start-up Hubs
Founders’ warm welcome in Barcelona
...This is aided by the fact that groups such as Novartis are based in the city, soon to be joined by AstraZeneca....
March 14, 2024
Dementia
UK biotech group raises £48mn for Alzheimer’s research
...Several international funds took part in the Series A round, which was led by Novartis Venture Fund and includes follow-on investment by the Dementia Discovery Fund....
October 8, 2023
Pharmaceuticals sector
Novo Nordisk and Eli Lilly hoover up smaller obesity drug groups
...likely to be examining potential deals to secure obesity medicines, said Field of Barclays, especially those that sold diabetes drugs, such as AstraZeneca and Sanofi, or cardio-metabolic treatments, such as Novartis...
October 24, 2023
Novartis AG
Novartis chief criticises EU move to control pharma licensing in emergencies
...Narasimhan is refocusing Novartis on pharmaceuticals and has disposed of the company’s consumer health and eyecare divisions....
April 25, 2023
The FT ViewThe editorial board
Britain’s life sciences sector needs a shot in the arm
...Britain is also falling down global rankings in running clinical trials; Novartis recently scrapped a major trial of a cholesterol drug....
October 18, 2023
Live news updates from July 18: BBC hires Deloitte to review procedures, Morgan Stanley profits fall
What to watch in Europe today
...Corporate results: Updates are expected from British private bank Arbuthnot, Swiss pharmaceutical giant Novartis, UK retailer Ocado, Anglo-Australian mining company Rio Tinto, Sweden’s Swedbank and UK fintech...
July 18, 2023

Previous pagePage 1 of 62Next page